Old Web
English
Sign In
Acemap
>
authorDetail
>
Andrea Schulze
Andrea Schulze
Bayer
Medicine
Physical therapy
Family medicine
Interferon beta-1b
Multiple sclerosis
4
Papers
86
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The 11-year long-term follow-up study from the randomized BENEFIT CIS trial
2016
Neurology
Ludwig Kappos
Gilles Edan
Mark Freedman
Xavier Montalban
Hans-Peter Hartung
Bernhard Hemmer
Edward Fox
Frederik Barkhof
Sven Schippling
Andrea Schulze
Dirk Pleimes
Christoph Pohl
Rupert Sandbrink
Gustavo Suarez
Eva-Maria Wicklein
Show All
Source
Cite
Save
Citations (80)
Long-term safety of interferon beta-1b (IFNB-1b) treatment in early multiple sclerosis ( MS): The 11-year follow-up of BENEFIT (BENEFIT-11)
2016
Multiple Sclerosis Journal
Mark S. Freedman
Ludwig Kappos
Gilles Edan
Xavier Montalban
Hans-Peter Hartung
Bernhard Hemmer
Edward Fox
Frederik Barkhof
Sven Schippling
Andrea Schulze
Dirk Pleimes
Christoph Pohl
Rupert Sandbrink
Gustavo Suarez
Eva-Maria Wicklein
Show All
Source
Cite
Save
Citations (0)
1